The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin

BACKGROUND: Peak anti-Xa activity of low-molecular-weight heparin nadroparin is measured 3 to 5 hours after subcutaneous injection. In critically ill patients, physiological changes and medical therapies may result in peak activities before or after this interval, possibly impacting dosing. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Sytema, Jelmer G., Loef, Bert G., Loovers, Harriët M., Boer, Marijn, Touw, Daniël J., van Hulst, Marinus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336191/
https://www.ncbi.nlm.nih.gov/pubmed/37449055
http://dx.doi.org/10.1016/j.rpth.2023.100185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336191/
https://www.ncbi.nlm.nih.gov/pubmed/37449055
http://dx.doi.org/10.1016/j.rpth.2023.100185

Ejemplares similares